OBJECTIVES: The aim of the study was to develop a multistranded pragmatic rehabilitation programme for operable lung cancer patients, that looks into feasibility, process indicators, outcome measures, local adaptability, compliance and potential cost benefit.
INTRODUCTION
Postoperative pulmonary complications (PPCs) are the leading cause of morbidity and mortality after lung resection surgery for lung cancer. In the UK, 3000 lung resections take place every year. The current rate of postoperative PPC in a large representative UK centre is 15%. PPCs increase patients' mortality from 0.5 to 12%, intensive care unit (ICU) admission rate from 1.5 to 26%, hospital length of stay (LOS) from 5 to 14 days and high dependency unit (HDU) LOS from 1 to 4 days [1] .
Advanced age (≥75 year old), American Society of Anaesthesiology (ASA) score of ≥3, current smoking, chronic obstructive pulmonary disease (COPD) and reduced mobility have been shown to be independent risk factors for developing PPCs [1] . It is unclear whether modifying these factors would make a difference to the rate of PPC.
Pulmonary rehabilitation programmes (PRPs) delivered by a multidisciplinary team to patients suffering from COPD are well established and widely practised in the UK. This comprehensive intervention includes exercise training, self-management education, smoking cessation advice and nutritional and psycho-social support [2] . PRPs not only improve lung function and exercise capacity, but also reduce PPCs, hospital admissions, frequency of exacerbations and dyspnoea [3] [4] [5] . The majority of patients undergoing surgery for lung cancer (73% of men and 53% of women) have COPD. Lung resection surgery for cancer could be considered an irreversible exacerbation of COPD; hence, a COPD-type rehabilitation programme in this group of patients may have significant clinical benefits.
Several small pilot studies have shown that preoperative PRP in lung cancer surgery improves exercise capacity [6, 7] and pulmonary function [8, 9] , but none has shown improvement in any significant clinical outcome.
The burden of PPC on the National Health Service (NHS) is set to increase since new European and UK guidelines [10] are more permissive in their criteria for the selection of surgery, and hence, additional patients who are less fit and more likely to develop PPC will be offered surgery. Thus, any intervention to reduce PPCs will have a valuable impact on clinical and cost-effectiveness outcomes.
We performed a study to develop, refine and examine the feasibility of applying a complex, pragmatic pre-and postoperative multidisciplinary PRP for operated lung cancer (ROC) patients.
METHODS
A prospective ethics approved enriched cohort study was conducted over an 18-month period. Inclusion criteria for the study were broad; any patient who was considered fit for curative lung cancer surgery by the lung cancer multidisciplinary team at a regional thoracic unit which based on the BTS guidelines [10] was invited to participate in the study. Patients from 3 of 12 referring hospitals were invited to be in the intervention group and join an existing COPD PRP. Patients from the remaining referring hospitals were in the control non-intervention group of the study.
Subjects were identified as potential surgical candidates for curative lung surgery at the cancer multidisciplinary meetings. The time spent on the PRP was flexible to fit the 'referral-to-treatment' target timeframe. Surgery was not delayed for the purposes of the programme. Patients in the intervention group join the PRP as early as possible, prior to all investigations or seeing a surgeon. This approach was taken to maximize patients' time on the programme, accepting that some patients may not finally undergo surgery.
The programme was developed from the COPD PRP template and refined by a core group of healthcare professionals involved in delivering the programme (lung cancer nurse specialists, thoracic surgeons, physicians, ward nurses, smoking cessation nurse, physiotherapists and Macmillan dieticians) and patient representatives to ensure that it remained patient centred. This group met prior to inception of the programme and then initially every 6 weeks for the first 6 months to discuss operations, outcomes and refine the programme. The programme was presented at every stage to the local lung cancer patients support group incorporating their feedback to fine tune the intervention. The programme was captured in a manual and DVD to help with compliance to the protocol (available on request). The programme was delivered solely to the intervention group.
Education and self-management
The education sessions were delivered by lung cancer nurse specialists and physiotherapists and included addressing the diet, smoking, lifestyle change, disease process and diagnosis, inpatient expectations, preparation for discharge and home, pain management, basics of breathing and benefits of mobility, coughing and airway clearance as well as ways of dealing with symptoms while outside the hospital.
Exercise training
The patient attended their local COPD rehabilitation exercise class twice weekly for 1 h, which included a combination of endurance and strength exercises as well as inspiratory muscle exercises. The patients in the intervention group trained up to 60% of their maximum exercise capacity guided by the BORG scale of breathlessness. The PRP was pragmatic in nature, permitting a degree of local adaptation. The exercise classes were delivered in hospital in two centres and in the community in one centre, using individualized programmes in two centres and group classes in the other.
Smoking cessation
All smokers were accelerated into locally available smoking cessation pathways. These included smoking advice, counselling and nicotine replacement therapy as appropriate.
Nutritional intervention
All patients had dietary advice by lung cancer nurse and a nutritional assessment, which included body mass index (BMI) as well as history of weight loss. If they met the criteria for dietary intervention (BMI <20, or 10% weight loss in the last 3 months), the patients were referred to a Macmillan dietician and received preoperative nutritional drink supplements, which continued for up to 3 months based on the subsequent postoperative nutritional assessment.
In-hospital journey
Both groups were treated as per unit protocol. All operations were performed through a thoracotomy incision, and patients were managed in a specialized thoracic HDU. Both groups were managed daily by a specialized thoracic team, and all received a daily physiotherapy programme from the first postoperative day. This included sitting out of bed, early mobilization, deep breathing exercises, assisted coughing augmented by nebulizers and humidified oxygen.
Data collected from both groups included demographic information, BMI, smoking status, percentage predicted in forced expiratory volume in 1 s (FEV 1 ), ASA score, eastern coperative oncology group (ECOG) performance status, postoperative predicted FEV 1 , European Society's Objective Score (ESOS), comorbidities, COPD status, LOS, HDU LOS, ICU admissions, readmission rate (for surgical complications) and mortality. The Melbourne Group Scale (Table 1 ) [11] was used daily by senior physiotherapists who were performing their routine respiratory assessments to assess patients for PPC.
For the intervention group, 6-min walk test (6MWT), weight, urine cotinine and exhaled carbon monoxide levels were measured, prerehabilitation, post-rehabilitation presurgery, 4 weeks post-surgery and then at 6 months.
Postoperatively
Between 4 and 6 weeks post-hospital discharge, the intervention group rejoined the rehabilitation programme twice weekly for up to 3 months and was then offered maintenance sessions once a week.
Economic assessment
The Pan Birmingham Cancer Network assisted by the Trust financial directorate and the local Primary Care Trust (PCT) commissioner defined the costs and benefits associated with the ROC programme. The cost of delivering the programme and cost savings associated with the reduction in complications were defined using the 2010/2011 service cost data. Cash releasing savings made by the central health authority for activity not covered by the tariff, i.e. complications; and non-cash releasing savings to the NHS Trust (e.g. reduction in LOS freeing up capacity) were calculated to provide cost savings in both arms of the study.
Statistical analysis
Differences in characteristics and outcomes between patients in the two study arms were compared using the Wilcoxon rank-sum test for non-normally distributed continuous data, and using χ 2 tests (with continuity correction) or Fisher's exact test where appropriate, for binary and categorical data. A multivariate logistic regression model was fitted to PPC using a backward elimination procedure with a 5% significance level. Changes in FEV 1 were compared using the Wilcoxon signed-rank test. All statistical analyses were performed using the SAS version 9.2 statistical software (SAS Institute, Inc., Cary, NC, USA).
RESULTS
At the completion of the study, 58 patients had joined the intervention group and 305 the non-intervention group. All the 58 patients completed the preoperative arm of the programme, but only 28 managed to attend the postoperative element. An additional 4 (6.5%) patients who were enrolled in the programme did not receive surgery because of patient choice (n = 1) or further investigations showed the patient did not have cancer (n = 2) or that the cancer was too advanced to be treated by surgery (n = 1) and have not been included in the analysis.
The median age was 69 (range 41-85) years for those in the intervention group and 67 years (range 21-88) in the nonintervention group. There were no significant differences between the groups in their preoperative characteristics, although there was a higher incidence of COPD in the intervention group of 36% compared with 23% in the non-intervention group (P = 0.05, Table 2 ). There was also a higher incidence of a confirmed pathology of cancer in the intervention (97%) compared with the non-intervention (87%) group (P = 0.07, Table 3 ), but similar patterns for the type of surgical resection (Fig. 1 ) and postoperative analgesia (Table 3) .
Patients waited a median of 5 (range 0-23) days to be seen in a rehabilitation class and attended four rehabilitation classes (range 1-15) and seven education sessions (range 2-13). Time from recruitment to seeing a surgeon was 0 (range −19 to 11) days. Only 28 (48%) patients rejoined the programme after surgery, attending a median of six sessions (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Reasons for the 30 patients not rejoining are outlined in Table 4 .
There was a significant improvement from pre-to postrehabilitation ( presurgery) in the 6MWT of 20 m (n = 30, range −73 to 195, P = 0.001). This was associated with a marked improvement from pre-to post-rehabilitation ( presurgery) in FEV 1 of 0.66 l (n = 43, range −1.85 to 1.11, P = 0.009). In contrast, there was a drop of 41 m in the postoperative 6MWT compared with preoperative ( post-rehabilitation) (n = 15, range −240 to 58, P = 0.005).
Of the 13 current smoking patients in the intervention group at baseline, 7 agreed to be referred to smoking cessation sessions and 6 of these patients stopped smoking, as confirmed by biochemical testing.
Nine (16%) patients were identified as being at risk of malnourishment due to recent weight loss, although none had a BMI of <20. There were too little data to comment on the efficacy of the nutritional supplementation.
Clinically relevant outcome measures are described in Table 5 for both groups. Patients in the intervention group experienced fewer PPC's than those in the non-intervention group (9 vs 16%, respectively, P = 0.21) and fewer readmissions (5 vs 14%, respectively, P = 0.12). A multivariate analysis identified COPD (P = 0.007) and smoking (P = 0.049) as significant factors for predicting PPC. Patients with COPD (odds ratio [OR] = 2.88, 95% confidence interval [95% CI] = 1.56-5.31) and smokers (OR = 1.90, 95% CI = 1.00-3.59) were at a higher risk of developing a PPC. After adjusting for COPD and smoking, having the intervention tended to reduce the risk of developing a PPC (OR = 0.40, 95% CI 0.13-1.01, P = 0.07).
The estimated extra cost of the ROC programme was calculated at £188.45 per patient. The total cost per patient in the intervention group including the cost of HDU/ITU usage, readmission rate and intervention cost was estimated at £1284 compared with £1528 per patient in the non-intervention group. Thus, the cost releasing savings from differences in HDU/ITU usage and readmission rate in the intervention group compared with the nonintervention group, taking the new service cost into account, were calculated at £244 per patient. 
DISCUSSION
In this study, we have defined, developed and refined a complex pragmatic outpatient-based pre-and post-surgical intervention and examined its feasibility in terms of delivery and outcome measures, all with the primary aim of optimizing and enhancing recovery and physical status of patients undergoing curative lung cancer surgery. In our experience, successfully delivering this multifaceted intervention in a regional surgical unit with 'feeder' hospitals required a co-ordinated multidisciplinary and organizational collaboration as well as a degree of flexibility in the programme to tailor to patients' individual needs and ability. Due to the complexity of the intervention, a degree of local adaption at each site where the programme was delivered was paramount for the programme to work effectively. Ultimately, this approach will facilitate other centres throughout the UK to adopt this model.
We took a pragmatic approach to the length and intensity of the programme to fit with cancer waiting time targets [12] . Surgery was never delayed due to the programme. As this is an exploratory study, we did not select patients but offered it to all, as many have modifiable risk factors for PPC [1] and we did not know which group of patients would benefit the most and from what part of intervention would they derive the most benefit. The selection criteria in other studies of preoperative PRP for lung cancer patients only included those with COPD, poor lung function and/or exercise capacity [6] [7] [8] [9] 13] . The presurgery PRP study's length varied from 2 to 4 weeks, similar to ours, but the intensity was far greater (usually five times a week) [6] [7] [8] sometimes as an inpatient [13] and delaying surgery [7] . There was a significant improvement in 6MWT in our study from pre-to postrehabilitation of 20 m (n = 30, range −73 to 195, P = 0.001). This effect size is smaller than reported by others probably because of the intensity and length of programmes and the selection of less-fit patients [7] [8] [9] . The reasons for not attending postoperative rehabilitation (Table 4) have to be explored further to develop a more effective postoperative limb to the programme.
In our study, there was a trend towards a reduction in the clinically important outcomes of PPC (16 vs 9%) and readmission due to complications (14 vs 5%) with the introduction of the ROC programme. This magnitude of benefit matches that reported following the introduction of a perioperative in-patient chest physiotherapy programme [14] . However, our findings contrast with other PRPs who report a high incidence of complications following PRP ranging from 35 to 73% [6] . Only one small study showed a reduced LOS in an intervention group of 22 patients compared with a historical control group of 60 patients. However, the LOS seen in both groups far exceeds that expected in a European setting (21 ± 6.8 vs 29 ± 9, P = 0.0003) and the study was not powered to test for this.
The effects of the individual contribution of the other elements of the programme are not separable in this study. While a number of patients in both groups gave up smoking >6 weeks before surgery, over 20% of patients continued to do so. With the help of a fast-track approach to local services in the PRP group, there was a 50% cessation rate confirmed biochemically. Smoking cessation before thoracic and other types of surgeries reduces the risk of developing complications [15] , but only done at least 4 weeks prior.
Nine (16%) intervention patients were referred to the dietician for assessment and high-energy drinks prescription, because of perceived risk of being malnourished as all had a self-reported history of recent weight loss. No patient had a BMI of <20. The current standards for nutritional intervention may not be adequate for this patient group who have two catabolic diagnoses: cancer and surgery. With such small numbers in our study, it was not possible to ascertain whether the intervention improved nutritional parameters. Poor nutritional status has been shown to adversely affect the postoperative recovery in patients undergoing lung resection surgery and has been identified as an important predictor of death [16] . It remains unproven whether optimization leads to better recovery and is an area that requires further investigation.
Patient empowerment and education are key principles in our ROC programme and an integral element of an Enhanced Recovery After Surgery (ERAS) pathway [17] . These components begin at first contact with the patient and are delivered by all members of the multidisciplinary team tailored to the individual patient needs [18] .
Identifying patient-centred outcome measures and how they affect clinical end-points is important but difficult.
Identifying outcomes of healthcare that matter to patients and assessing them using high-quality patient-reported outcome measures (PROMs) is an important current focus of NHS [19] . The arrival of NHS commissioning boards in April 2013 [20] will stress the importance of PROMs and their integration into future research.
Throughout this study, the willingness of clinicians and participants to take part in the programme has been very positive. Clinicians feel there is a real need for this type of programme, and participants report gaining control over their diagnosis and treatment. Attending exercise and education classes twice-a-week has prepared the patient and their families for the surgical journey.
The poor uptake of postoperative PRP is an area for further development. More patients receive adjuvant therapy and the ageing population find it more difficult to get back to PRP classes. It may be that alternative postoperative PRP approaches are required, which could include better use of audiovisual aids such as DVDs and care at home.
This programme is brought to the forefront of the enhanced recovery drive, which has spread from its four original surgical specialities to now include thoracic surgery. Thus, the concept of enhancing the patients' physical and respiratory health prior to lung surgery is vitally important to the NHS. (13) 3 (5) Not recorded 5 (2) 1 (2) IT: Intrathecal; PCA: patient-controlled analgesia. A COPD-type PRP programme, which seeks to globally address issues of nutrition, smoking status, preoperative exercise capacity and lung function, all modifiable risk factors of pulmonary complications, is viable. The new British Thoracic Society and European guidelines for the selection of surgery are more permissive with a view to improving long-term outcomes of lung cancer. The guidelines clearly state the need to optimize risk factors prior to surgery, but the evidence for such intervention is lacking. This study represents the first step to generating stronger evidence in support of this. In addition, it shows that we can deliver an intervention within the time constraints of surgical waiting times using locally available and variable COPD resources. To investigate its efficacy, identify the optimum length of time of programme, identify which subgroups benefit greatest and assess the contribution of each element requires a randomized control trial. In this time of financial constraint, we have laid a template of cost saving, which also needs to be tested from a wider health economic perspective. Finally, the long-term effects on quality of life and symptoms of breathlessness after surgery need to be evaluated.
